Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125222) titled 'Use of Gocovri to Improve Disability Due to Radiation Encephalopathy' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Weill Medical College of Cornell University
Condition:
Radiation Encephalopathy
Intervention:
Drug: Gocovri (extended-release amantidine)
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 2025
Target Sample Size: 24
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT...